-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JLvdOBTyQn/M8BrRjU838+E9eHtcXXvzuxQyOfFa20bjesrYIuKsPPhiclG7408b uROcj01zrFZLxdNASTYibQ== 0000947871-99-000060.txt : 19990217 0000947871-99-000060.hdr.sgml : 19990217 ACCESSION NUMBER: 0000947871-99-000060 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-48459 FILM NUMBER: 99543193 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CITIBANK NA CENTRAL INDEX KEY: 0000036684 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 135266470 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10043 BUSINESS PHONE: 2125591000 MAIL ADDRESS: STREET 1: C/O LEGAL AFFAIRS OFFICE STREET 2: 425 PARK AVENUE 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10043 FORMER COMPANY: FORMER CONFORMED NAME: FIRST NATIONAL CITY BANK OF NEW YORK DATE OF NAME CHANGE: 19820322 SC 13G/A 1 AMENDMENT TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------------------------------------------------------------ SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) CELL THERAPEUTICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 0001509341 (CUSIP Number) - ------------------------------------------------------------------------------- Check the following box if a fee is being paid with this statement. [ ] 2 CUSIP No. 0001509341 (1) Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Citibank, N.A.; 13-5266470 ---------------------------------------------------------------------- ---------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of Group (See Instructions) [ ] (a) ----------------------------------------------------------------- [ ] (b) ----------------------------------------------------------------- (3) SEC Use Only --------------------------------------------------------- ---------------------------------------------------------------------- (4) Citizenship or Place of Organization New York --------------------------------- Number of (5) Sole Voting Power 0 Shares ----------------------------------- Beneficially ------------------------------------------------------------- Owned by (6) Shared Voting Power 631,655 Each --------------------------------- Reporting ------------------------------------------------------------- Person (7) Sole Dispositive Power 0 With ------------------------------ ------------ ------------------------------------------------------------- (8) Shared Dispositive Power 631,655 ---------------------------- ------------------------------------------------------------- ------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 631,655 ---------------------------------------------------------------------- (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ---------------------------------------------------------------------- ---------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9) 4.1% ---------------------------------------------------------------------- (12) Type of Reporting Person (See Instructions) BK* -------------------------- --------------- * The reporting person is a pledgee with limited voting and dispositive power pursuant to certain voting trust agreements. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 13 or for any other purpose. 3 Item 1. Issuer (a) Cell Therapeutics, Inc. (b) 201 Elliott Avenue, W., Suite 400 Seattle, WA 98119 Item 2. Persons Filing (a) Name of Persons Filing: Citibank, N.A. (b) Address of Principal Offices: 399 Park Avenue, New York, New York 10043 (Citibank, N.A.) (c) Citizenship: New York (Citibank, N.A.) (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 0001509341 Item 3. If this Statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Act (b) [XX] Bank as defined in Section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment Company registered under Section 8 of the Investment Company Act (e) [ ] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see ss. 240.13d-1(b)(1)(ii)(F) (g) [ ] Parent Holding Company, in accordance with ss. 240.13d-1(b)(ii)(G) (h) [ ] Group in accordance with ss. 240.13d-1(b)(1)(ii)(G) Item 4. Ownership (a) Citibank, N.A.: 631,655; (b) Citibank, N.A.: 4.1%; 4 (c) (i) -0-; (ii) Citibank, N.A.: 631,655; (iii) -0-; (iv) Citibank, N.A.: 631,655. Item 5. Ownership of Five Percent or Less of a Class This statement is being filed to report that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities. [ ] Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not Applicable. Item 9. Notice of Dissolution of Group Not Applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 16, 1999 CITIBANK, N.A. By: /s/ Melissa Tanklefsky ---------------------------- Name: Melissa Tanklefsky Title: Vice President -----END PRIVACY-ENHANCED MESSAGE-----